5 Currently treated with 1 or 2 AEDs any except OXC in a stable dose regimen during at least 1 month prior to screening Patients using vigabatrin should have been on this medication for at least 1 year with no deficit in visual field identified a confirmatory test should be available within 1 month before study entry The device for VNS should be implanted at least 6 months before screening parameters need to be stable for at least 1 month prior to screening VNS will not be counted as concomitant AED 